Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity

ACS Synthetic Biology
Patrick HoYvonne Y Chen

Abstract

Targeted therapies promise to increase the safety and efficacy of treatments against diseases ranging from cancer to viral infections. However, the vast majority of targeted therapeutics relies on the recognition of extracellular biomarkers, which are rarely restricted to diseased cells and are thus prone to severe and sometimes-fatal off-target toxicities. In contrast, intracellular antigens present a diverse yet underutilized repertoire of disease markers. Here, we report a protein-based therapeutic platform-termed Cytoplasmic Oncoprotein VErifier and Response Trigger (COVERT)-which enables the interrogation of intracellular proteases to trigger targeted cytotoxicity. COVERT molecules consist of the cytotoxic protein granzyme B (GrB) fused to an inhibitory N-terminal peptide, which can be removed by researcher-specified proteases to activate GrB function. We demonstrate that fusion of a small ubiquitin-like modifier 1 (SUMO1) protein to GrB yields a SUMO-GrB molecule that is specifically activated by the cancer-associated sentrin-specific protease 1 (SENP1). SUMO-GrB selectively triggers apoptotic phenotypes in HEK293T cells that overexpress SENP1, and it is highly sensitive to different SENP1 levels across cell lines. We fur...Continue Reading

References

Jan 1, 1987·Annual Review of Biochemistry·J S Bond, P E Butler
Feb 8, 1995·International Journal of Cancer. Journal International Du Cancer·P DallH Ponta
Feb 1, 1995·Experimental Cell Research·L M Desjardins, J P MacManus
Sep 15, 1993·Biochemical and Biophysical Research Communications·J A TrapaniM J Smyth
Feb 11, 1999·Biochemical Pharmacology·C D Bortner, J A Cidlowski
Jan 16, 2002·Genome Biology·J A Trapani
Apr 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Priscilla Y YamJiing-Kuan Yee
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jun 21, 2002·Biochemical and Biophysical Research Communications·Rachel B KapustDavid S Waugh
May 10, 2003·Journal of Immunological Methods·Catherine EwenJanet E McElhaney
May 27, 2003·Nature Reviews. Immunology·Judy Lieberman
Oct 18, 2003·The Journal of Biological Chemistry·Daniel Bailey, Peter O'Hare
Dec 30, 2004·The Journal of Clinical Endocrinology and Metabolism·Caroline JacquesPascal Reynier
Sep 10, 2005·Nature Biotechnology·Anna M Wu, Peter D Senter
Sep 10, 2005·Nature Biotechnology·Gregory P Adams, Louis M Weiner
Nov 5, 2005·Biochimica Et Biophysica Acta·Onno Kranenburg
Aug 24, 2006·Neoplasia : an International Journal for Oncology Research·Jinke ChengEdward T H Yeh
Aug 25, 2006·Nature Reviews. Cancer·Kohzoh Imai, Akinori Takaoka
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
Jun 12, 2010·Immunological Reviews·Michael L Dustin, Eric O Long
Jun 12, 2010·Immunological Reviews·Ilia VoskoboinikJoseph A Trapani
Jul 2, 2010·The Biochemical Journal·Nagamalleswari KolliKeith D Wilkinson
Dec 16, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria R ParkhurstSteven A Rosenberg
Apr 3, 2012·Cell·Chi V Dang
Jul 28, 2012·Oncotarget·Samuel R Denmeade, John T Isaacs
Nov 24, 2012·Nature Reviews. Molecular Cell Biology·Christopher M HickeyMark Hochstrasser
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Levi A Garraway
Jun 12, 2013·Annual Review of Biochemistry·Annette Flotho, Frauke Melchior
Oct 22, 2013·Nature Biotechnology·Christian S Hinrichs, Nicholas P Restifo
Feb 19, 2014·Cancer Gene Therapy·Steven A Rosenberg
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Sep 14, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chenchao MaKaixing Ai
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Jan 18, 2015·Molecular Immunology·Connie P M DuongPhillip K Darcy
Jun 5, 2015·Future Oncology·Domenico Mattoscio, Susanna Chiocca
Oct 7, 2015·Trends in Immunology·Yvonne Y Chen
Nov 12, 2016·Trends in Pharmacological Sciences·James R KintzingJennifer R Cochran
Nov 23, 2016·Trends in Pharmacological Sciences·Dearbhaile C CollinsTimothy A Yap

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.